Stay updated on Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page.
Latest updates to the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedLocations section added with Ohio as a listed location. Ohio Locations and the HHS Vulnerability Disclosure footer were removed.SummaryDifference0.2%
- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2; this is a minor UI/version change and does not affect study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check56 days agoChange DetectedRemoved the government funding lapse banner from the page, an administrative notice not affecting study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check78 days agoChange DetectedA newer last update date and verification timestamps appear in Study Record Dates, while core study details (status, enrollment, eligibility, and procedures) remain unchanged.SummaryDifference0.3%
- Check99 days agoChange DetectedThe page now includes a government-operating status notice and a new resource topic, bumps the revision to v3.2.0, and removes the old v3.1.0 reference.SummaryDifference3%
- Check107 days agoChange DetectedUpdated page to version v3.1.0 and removed the topic 'Diffuse large B-cell lymphoma' from resources; this indicates a targeted removal of a specific disease topic from core content.SummaryDifference0.4%
Stay in the know with updates to Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with DA-REPOCH for B-Cell Lymphoma Clinical Trial page.